Found: 24
Select item for more details and to access through your institution.
ras Oncogene Activation and Occupational Exposures in Acute Myeloid Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 21, p. 1626
- By:
- Publication type:
- Article
Thrombotic Thrombocytopenic Purpura: Combined Treatment with Plasmapheresis and Antiplatelet Agents.
- Published in:
- Annals of Internal Medicine, 1980, v. 92, n. 2, p. 149, doi. 10.7326/0003-4819-92-2-149
- By:
- Publication type:
- Article
Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 6, p. 987, doi. 10.1111/bjh.13552
- By:
- Publication type:
- Article
Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD.
- Published in:
- Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 2, p. 85, doi. 10.1177/1078155209354932
- By:
- Publication type:
- Article
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00204-7
- By:
- Publication type:
- Article
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 2, p. 122
- By:
- Publication type:
- Article
Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
- Published in:
- Journal of Cellular Biochemistry, 1988, v. 36, n. 4, p. 445, doi. 10.1002/jcb.240360412
- By:
- Publication type:
- Article
Update in hematology.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. 1, p. 1, doi. 10.1111/j.1600-0609.1998.tb01053.x
- By:
- Publication type:
- Article
Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation.
- Published in:
- American Journal of Hematology, 1989, v. 32, n. 2, p. 81, doi. 10.1002/ajh.2830320202
- By:
- Publication type:
- Article
Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920976366
- By:
- Publication type:
- Article
Toxicity-evaluation designs for phase I/II cancer immunotherapy trials.
- Published in:
- Statistics in Medicine, 2010, v. 29, n. 7/8, p. 712, doi. 10.1002/sim.3799
- By:
- Publication type:
- Article
Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
- Published in:
- Transfusion, 2014, v. 54, n. 7, p. 1857, doi. 10.1111/trf.12529
- By:
- Publication type:
- Article
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage–colony-stimulating factor and granulocyte–colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation
- Published in:
- Transfusion, 2007, v. 47, n. 11, p. 2153, doi. 10.1111/j.1537-2995.2007.01440.x
- By:
- Publication type:
- Article
Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non- Hodgkin's Lymphoma or Multiple Myeloma.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 7, p. 596, doi. 10.1002/j.1875-9114.2012.01096.x
- By:
- Publication type:
- Article
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 418, doi. 10.1002/cncr.26292
- By:
- Publication type:
- Article
Restricted usage of V.
- Published in:
- European Journal of Immunology, 1989, v. 19, n. 9, p. 1741, doi. 10.1002/eji.1830190932
- By:
- Publication type:
- Article
MHC-I genotype and tumor mutational burden predict response to immunotherapy.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-00743-4
- By:
- Publication type:
- Article
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
- Published in:
- British Journal of Haematology, 1996, v. 93, n. 2, p. 375, doi. 10.1046/j.1365-2141.1996.4991043.x
- By:
- Publication type:
- Article
Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor.
- Published in:
- British Journal of Haematology, 1995, v. 91, n. 2, p. 269, doi. 10.1111/j.1365-2141.1995.tb05289.x
- By:
- Publication type:
- Article
Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells.
- Published in:
- British Journal of Haematology, 1995, v. 89, n. 4, p. 712, doi. 10.1111/j.1365-2141.1995.tb08406.x
- By:
- Publication type:
- Article